Skip to main content
Pfizer COVID-19 vaccine appointments are available to our patients.
Sign up for Connect today
to schedule your vaccination.
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
Joint Clinical Trials Office
Explore this Website
Home
About
Toggle About menu options
News
JCTO Contacts
Careers
Our Clinical Trial Locations
Partner with the JCTO
Toggle Partner with the JCTO menu options
JCTO Fees
Open Clinical Trials
Investigators
Patients
Toggle Patients menu options
What is a Clinical Trial?
Frequently Asked Questions
Clinical Trial Questions to Ask Your Healthcare Team
Clinical Trials: Common Terms to Know
Understanding Clinical Trials and How They Work
Understanding Clinical Trials - In Spanish | En Español
Weill Cornell Medicine
Care
Discover
Teach
Home
About
Open Clinical Trials
Investigators
Patients
Home
Clinical Trials
Phase 1/2 Study of IDP-023 as a Single Agent and in Combination with Antibody Therapies in Patients with Advanced Hematologic Cancers
Study Status:
Open to Enrollment
Primary Investigator:
Date:
March 11, 2024
Platform Study of Immunotherapy Combinations in Colorectal Cancer Liver Metastases
Study Status:
Open to Enrollment
Primary Investigator:
Date:
March 11, 2024
A Study of PARG Inhibitor IDE161 in Participants with Advanced Solid Tumors
Study Status:
Open to Enrollment
Primary Investigator:
Date:
March 11, 2024
Evaluation Of Talazoparib, a PARP Inhibitor, In Patients With Somatic BRCA Mutant Metastatic Breast Cancer: Genotyping Based Clinical Trial
Study Status:
Open to Enrollment
Primary Investigator:
Date:
March 11, 2024
A Phase I/II Study of M3814 and Avelumab in Combination with Hypofractionated Radiation in Patients with Advanced/Metastatic Solid Tumors and Hepatobiliary Malignancies
Study Status:
Open to Enrollment
Primary Investigator:
Date:
March 15, 2024
A Phase 3 Trial Investigating Blinatumomab in Combination with Chemotherapy in Patients with Newly Diagnosed Standard Risk or Down syndrome B-Lymphoblastic Leukemia (B-ALL) and the Treatment of Patients with Localized B-Lymphoblastic Lymphoma (B-LLy)
Study Status:
Open to Enrollment
Primary Investigator:
Date:
March 15, 2024
A Randomized, Multi-Center, Pivotal Efficacy and Safety Study Evaluating the EndoBarrier® System for Glycemic Improvement in Patients with Inadequately Controlled Type 2 Diabetes and Obesity
Study Status:
Open to Enrollment
Primary Investigator:
Date:
March 29, 2024
A Phase 1/2 Open-Label, Dose-Escalation and Cohort Expansion Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ARV-766 Monotherapy and in Combination with Abiraterone in Patients with Metastatic Prostate Cancer
Study Status:
Open to Enrollment
Primary Investigator:
Date:
April 2, 2024
Targeting CD38 with Daratumumab in Primary Antiphospholipid Syndrome: A Phase 1b Dose Escalation Safety Trial
Study Status:
Open to Enrollment
Primary Investigator:
Date:
April 2, 2024
An Adaptive Phase 3, Randomized, Open-Label, Multicenter Study to Compare the Efficacy and Safety of Axicabtagene Ciloleucel versus Standard of Care Therapy as First-Line Therapy in Subjects with High-Risk Large B-Cell Lymphoma (ZUMA-23)
Study Status:
Open to Enrollment
Primary Investigator:
Date:
April 2, 2024
« first
‹ previous
…
16
17
18
19
20
(current)
21
22
23
24
…
next ›
last »